Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
SHISA9 Blocking Peptide (AC1301)
Cat.#: ACPP-1301
Specifications
Despition SHISA9 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1039 Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) 50 µg inquiry ACPP-1413 Human STX3 Protein (AC1413) 5 µg inquiry ACPP-1815 Human HAAO Protein (AC1815) 2 µg inquiry ACPP-1153 MERTK Blocking Peptide (AC1153) 250 µg inquiry ACPP-1523 RPE65 Blocking Peptide (AC1523) 250 µg inquiry ACPP-1600 Mouse IL 6 Protein, Sf9 (AC1600) 2 µg inquiry ACPP-1247 GSK3 beta Blocking Peptide (AC1247) 250 µg inquiry ACPP-1444 Human VAMP2 Protein (AC1444) 5 µg inquiry ACPP-1076 Synaptophysin Blocking Peptide (AC1076) 250 µg inquiry ACPP-1401 Rat Midkine Protein (AC1401) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket